Alpha hemoglobinophaties in Rosario, Argentina

IF 0.6 Q4 HEMATOLOGY Thalassemia Reports Pub Date : 2016-12-28 DOI:10.4081/THAL.2017.5655
M. Ojeda, S. Pérez, A. Pratti, K. Calvo, M. Raviola, M. Voss, G. M. Williams, N. Noguera, María Magdalena Carbonell, M. Aixalá, I. Bragós
{"title":"Alpha hemoglobinophaties in Rosario, Argentina","authors":"M. Ojeda, S. Pérez, A. Pratti, K. Calvo, M. Raviola, M. Voss, G. M. Williams, N. Noguera, María Magdalena Carbonell, M. Aixalá, I. Bragós","doi":"10.4081/THAL.2017.5655","DOIUrl":null,"url":null,"abstract":"Hemoglobinopathies are the most common recessive diseases worldwide. While the molecular basis of β -thalassemia in Rosario has been addressed, that of α-thalassemia and α structural alterations, has not. In this study 105 individuals from different families referred to our center were investigated for alpha hemoglobinopathies because of low MCV (15%. Six of them with a clinical phenotype of thalassemia intermedia were diagnosed as Hb H disease (five cases) and Hb H like (one case). It also included one patient with sickle cell trait, confirmed by hematological and molecular studies. We were able to identify alpha globin genes mutations in 92 individuals (87.6%): 88 patients with alpha thalassemia, 3 patients with structural alterations and one with both. In total, 13 individuals (12.4%) had no identified α-globin mutation. This study is the first to deal with the molecular basis of α-hemoglobinophaties in Rosario. 血红蛋白病是全世界最常见的隐性疾病。 尽管我们已对罗萨里奥β地中海贫血的分子基础作出阐述,但是α地中海贫血和α结构性变化的分子基础尚未得到阐明。 在本研究中,105例来自不同家庭转诊至我中心的个体因MCV低(15%而接受了α血红蛋白病调查。 他们中具有中间型地中海贫血临床表型的六例被诊断为Hb H病(五例)和Hb H样(一例)。 其中还包括一例通过血液学和分子研究证实具有镰状细胞特征的患者 。 我们能够在92例个体(87.6%)中识别出α珠蛋白基因突变:88例有α地中海贫血 ,3例有结构性变化,还有一例两者均有。 总计13例个体(12.4%)未被识别出有α珠蛋白突变。 本研究是第一项针对罗萨里奥α地中海贫血分子基础的研究。","PeriodicalId":22261,"journal":{"name":"Thalassemia Reports","volume":"7 1","pages":""},"PeriodicalIF":0.6000,"publicationDate":"2016-12-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.4081/THAL.2017.5655","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Thalassemia Reports","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4081/THAL.2017.5655","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"HEMATOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Hemoglobinopathies are the most common recessive diseases worldwide. While the molecular basis of β -thalassemia in Rosario has been addressed, that of α-thalassemia and α structural alterations, has not. In this study 105 individuals from different families referred to our center were investigated for alpha hemoglobinopathies because of low MCV (15%. Six of them with a clinical phenotype of thalassemia intermedia were diagnosed as Hb H disease (five cases) and Hb H like (one case). It also included one patient with sickle cell trait, confirmed by hematological and molecular studies. We were able to identify alpha globin genes mutations in 92 individuals (87.6%): 88 patients with alpha thalassemia, 3 patients with structural alterations and one with both. In total, 13 individuals (12.4%) had no identified α-globin mutation. This study is the first to deal with the molecular basis of α-hemoglobinophaties in Rosario. 血红蛋白病是全世界最常见的隐性疾病。 尽管我们已对罗萨里奥β地中海贫血的分子基础作出阐述,但是α地中海贫血和α结构性变化的分子基础尚未得到阐明。 在本研究中,105例来自不同家庭转诊至我中心的个体因MCV低(15%而接受了α血红蛋白病调查。 他们中具有中间型地中海贫血临床表型的六例被诊断为Hb H病(五例)和Hb H样(一例)。 其中还包括一例通过血液学和分子研究证实具有镰状细胞特征的患者 。 我们能够在92例个体(87.6%)中识别出α珠蛋白基因突变:88例有α地中海贫血 ,3例有结构性变化,还有一例两者均有。 总计13例个体(12.4%)未被识别出有α珠蛋白突变。 本研究是第一项针对罗萨里奥α地中海贫血分子基础的研究。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
阿根廷罗萨里奥的阿尔法血红蛋白患者
血红蛋白病是世界上最常见的隐性疾病。虽然罗萨里奥β -地中海贫血的分子基础已经得到解决,但α-地中海贫血和α结构改变的分子基础尚未得到解决。在这项研究中,105名来自不同家庭的个体被转介到我们的中心,调查了由于低MCV(15%)而导致的α血红蛋白病。其中6例临床表型为地中海贫血中间型,诊断为Hb H病(5例)和Hb H样(1例)。它还包括一名患者镰状细胞特征,经血液学和分子研究证实。我们能够在92个个体(87.6%)中识别α -珠蛋白基因突变:88例α -地中海贫血患者,3例结构改变患者,1例两者都有。共有13人(12.4%)未发现α-珠蛋白突变。这项研究是第一个处理罗萨里奥α-血红蛋白增多症的分子基础。血红蛋白病是全世界最常见的隐性疾病。 尽管我们已对罗萨里奥β地中海贫血的分子基础作出阐述,但是α地中海贫血和α结构性变化的分子基础尚未得到阐明。巴巴巴巴巴巴巴巴巴巴巴巴巴巴巴巴巴巴巴巴巴巴巴巴巴巴巴巴巴巴巴巴巴巴巴巴巴巴巴巴巴巴巴巴巴巴巴巴巴巴巴巴巴巴巴巴巴巴巴巴巴巴巴巴巴巴巴巴巴巴巴巴巴巴巴巴巴巴巴巴巴巴巴巴巴巴巴巴巴巴巴巴巴巴巴巴巴巴巴巴巴巴巴巴巴巴巴巴巴巴巴巴巴巴巴巴巴巴巴巴巴巴巴巴。http://www.hb H。其中还包括一例通过血液学和分子研究证实具有镰状细胞特征的患者 。 我们能够在92例个体(87.6%)中识别出α珠蛋白基因突变:88例有α地中海贫血,3例有结构性变化,还有一例两者均有。(12.4%)这是一个很好的例子。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Thalassemia Reports
Thalassemia Reports HEMATOLOGY-
自引率
0.00%
发文量
17
审稿时长
10 weeks
期刊最新文献
β Thalassemia Mutation Flow in Indonesia: A Migration Perspective Amlodipine Therapy in β-Thalassemia Patients: A Systematic Review and Meta-Analysis on Ferritin Levels and Liver MRI T2* Association of Bone Disorder and Gene Polymorphism of PPAR-γ Pro12 Ala in Egyptian Children with β-Thalassemia Infection and Potential Challenge of Childhood Mortality in Sickle Cell Disease: A Comprehensive Review of the Literature from a Global Perspective Association between Glomerular Filtration Rate and β-Thalassemia Major: A Systematic Review and Meta-Analysis
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1